• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声、大小和细胞学诊断为 Bethesda Ⅲ类的甲状腺结节的风险分层。

Risk Stratification of Thyroid Nodules Diagnosed as Bethesda Category III by Ultrasound, Size, and Cytology.

机构信息

Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.

Department of Radiology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea.

出版信息

Korean J Radiol. 2024 Oct;25(10):924-933. doi: 10.3348/kjr.2024.0292.

DOI:10.3348/kjr.2024.0292
PMID:39344549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11444854/
Abstract

OBJECTIVE

This study aimed to evaluate the performance of an integrated risk stratification system (RSS) based on ultrasound (US) RSSs, nodule size, and cytology subcategory for diagnosing malignancy in thyroid nodules initially identified as Bethesda category III on fine-needle aspiration.

MATERIALS AND METHODS

This retrospective study was conducted at two institutions and included consecutive patients with Bethesda category III nodules, and final diagnoses confirmed by repeat biopsy or surgery. A total of 320 Bethesda category III nodules (≥1 cm) from 309 patients (223 female and 86 male; mean age, 50.9 ± 12.0 years) were included. The malignancy risk of Bethesda category III nodules and predictors of malignancy were assessed according to US RSSs, nodule size, and cytology subcategory. The diagnostic performances of US-size cytology (USC) RSS and US RSS alone for malignancy were compared.

RESULTS

The intermediate or high suspicion US category independently increased the malignancy risk in all US RSSs ( ≤ 0.001). Large nodule size (≥3 cm) independently increased the malignancy risk of low- or intermediate suspicion US category nodules. Additionally, the atypia of undetermined significance cytology subcategory independently increased the malignancy risk of low suspicion US category nodules in most US RSSs. The area under the receiver operating characteristic curve of the USC RSSs was greater than that of the US RSSs alone ( < 0.048). Malignancy was not found in the very low risk category of USC RSS.

CONCLUSION

The diagnostic performance of USC RSS for malignancy was superior to that of US RSS alone in Bethesda category III nodules. Malignancy can be ruled out in the very low-risk category of USC RSS.

摘要

目的

本研究旨在评估一种基于超声(US)风险分层系统(RSS)、结节大小和细胞学亚分类的综合风险分层系统(RSS)在经细针抽吸后最初被诊断为 Bethesda 分类 III 的甲状腺结节中诊断恶性肿瘤的性能。

材料和方法

本回顾性研究在两个机构进行,纳入了连续的 Bethesda 分类 III 结节患者,最终诊断通过重复活检或手术证实。共纳入 309 例患者的 320 个 Bethesda 分类 III 结节(≥1cm)(223 例女性,86 例男性;平均年龄 50.9±12.0 岁)。根据 US RSS、结节大小和细胞学亚分类评估 Bethesda 分类 III 结节的恶性风险和恶性肿瘤的预测因素。比较了 US-大小细胞学(USC)RSS 和单独使用 US RSS 对恶性肿瘤的诊断性能。

结果

中间或高度可疑的 US 类别独立增加了所有 US RSS 中的恶性风险(≤0.001)。大结节大小(≥3cm)独立增加了低或中可疑 US 类别的结节的恶性风险。此外,在大多数 US RSS 中,不明确意义的细胞学亚类的不典型性独立增加了低可疑 US 类别的结节的恶性风险。USC RSS 的受试者工作特征曲线下面积大于单独使用 US RSS(<0.048)。在 USC RSS 的极低风险类别中未发现恶性肿瘤。

结论

在 Bethesda 分类 III 结节中,USC RSS 对恶性肿瘤的诊断性能优于单独使用 US RSS。在 USC RSS 的极低风险类别中可以排除恶性肿瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2522/11444854/7e577aee0147/kjr-25-924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2522/11444854/7e577aee0147/kjr-25-924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2522/11444854/7e577aee0147/kjr-25-924-g001.jpg

相似文献

1
Risk Stratification of Thyroid Nodules Diagnosed as Bethesda Category III by Ultrasound, Size, and Cytology.超声、大小和细胞学诊断为 Bethesda Ⅲ类的甲状腺结节的风险分层。
Korean J Radiol. 2024 Oct;25(10):924-933. doi: 10.3348/kjr.2024.0292.
2
Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.基于细针抽吸细胞学和韩国甲状腺影像报告和数据系统的细胞学-超声风险分层评分系统。
Thyroid. 2017 Jul;27(7):953-959. doi: 10.1089/thy.2016.0603. Epub 2017 May 19.
3
Importance of cytological subclassification of thyroid nodules with Bethesda category III cytology (AUS/FLUS) into architectural atypia only and nuclear atypia: A prospective study.将贝塞斯达III类(意义不明确的非典型鳞状细胞/意义不明确的滤泡性病变)甲状腺结节细分为仅具有结构异型性和核异型性的细胞学亚分类的重要性:一项前瞻性研究。
Diagn Cytopathol. 2017 Jul;45(7):604-607. doi: 10.1002/dc.23734. Epub 2017 Apr 19.
4
Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.具有非典型性或意义未明的滤泡性病变的甲状腺结节(贝塞斯达Ⅲ类):超声检查和细胞学亚类的重要性
Thyroid. 2014 Jul;24(7):1115-20. doi: 10.1089/thy.2013.0650. Epub 2014 May 9.
5
Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.美国放射学院甲状腺影像报告和数据系统(ACR TI-RADS)评分较高是否预示恶性风险增加?评估甲状腺结节时 ACR TI-RADS 与细针穿刺细胞学的相关性研究。
Cancer Cytopathol. 2020 Jul;128(7):470-481. doi: 10.1002/cncy.22254. Epub 2020 Feb 20.
6
Approach to Bethesda system category III thyroid nodules according to US-risk stratification.根据美国风险分层,贝塞斯达系统类别 III 甲状腺结节的处理方法。
Endocr J. 2022 Jan 28;69(1):67-74. doi: 10.1507/endocrj.EJ21-0300. Epub 2021 Aug 18.
7
Ultrasound is helpful to differentiate Bethesda class III thyroid nodules: A PRISMA-compliant systematic review and meta-analysis.超声有助于鉴别贝塞斯达Ⅲ类甲状腺结节:一项遵循PRISMA规范的系统评价和荟萃分析。
Medicine (Baltimore). 2017 Apr;96(16):e6564. doi: 10.1097/MD.0000000000006564.
8
Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.超声 K-TIRADS 分类与 2015 年 ATA 指南在甲状腺结节及滤泡性肿瘤良恶性危险分层中的诊断效能
AJR Am J Roentgenol. 2019 Aug;213(2):444-450. doi: 10.2214/AJR.18.20961. Epub 2019 Apr 30.
9
ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.ACR TI-RADS 与 ATA US 评分有助于对具有不确定细胞学特征的甲状腺结节进行管理。
BMC Endocr Disord. 2019 Oct 29;19(1):112. doi: 10.1186/s12902-019-0429-5.
10
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).甲状腺结节分类为贝塞斯达Ⅲ类(不典型/意义未明的滤泡性病变)的恶性率。
Thyroid. 2014 May;24(5):832-9. doi: 10.1089/thy.2013.0317. Epub 2014 Mar 10.

引用本文的文献

1
Prediction of malignancy risk in Bethesda III nodules: development and validation of multiple machine learning models.贝塞斯达III类结节恶性风险的预测:多种机器学习模型的开发与验证
Front Endocrinol (Lausanne). 2025 Aug 29;16:1655828. doi: 10.3389/fendo.2025.1655828. eCollection 2025.
2
A Novel Scoring System for AUS Thyroid Nodule.一种用于AUS甲状腺结节的新型评分系统。
Int J Endocrinol. 2025 Aug 12;2025:6736469. doi: 10.1155/ije/6736469. eCollection 2025.

本文引用的文献

1
The 2023 Bethesda System for Reporting Thyroid Cytopathology.2023 年甲状腺细胞病理学报告的贝塞斯达系统。
Thyroid. 2023 Sep;33(9):1039-1044. doi: 10.1089/thy.2023.0141. Epub 2023 Jul 8.
2
2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.2023 年欧洲甲状腺协会甲状腺结节管理临床实践指南。
Eur Thyroid J. 2023 Aug 14;12(5). doi: 10.1530/ETJ-23-0067. Print 2023 Oct 1.
3
Malignancy Risk of Thyroid Nodules That Are Not Classifiable by the American Thyroid Association Ultrasound Risk Stratification System: A Systematic Review and Meta-Analysis.
甲状腺结节恶性风险不能用美国甲状腺协会超声风险分层系统进行分类:系统评价和荟萃分析。
Thyroid. 2023 May;33(5):593-602. doi: 10.1089/thy.2022.0672. Epub 2023 Apr 13.
4
SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Synthesis and algorithms.《2022年甲状腺结节管理的SFE-AFCE-SFMN共识:综合与算法》
Ann Endocrinol (Paris). 2022 Dec;83(6):440-453. doi: 10.1016/j.ando.2022.11.001. Epub 2022 Nov 4.
5
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.甲状腺癌临床实践指南(NCCN 指南)2022 年第 2 版。
J Natl Compr Canc Netw. 2022 Aug;20(8):925-951. doi: 10.6004/jnccn.2022.0040.
6
Cancer risk estimation using American College of Radiology Thyroid Imaging Reporting and Data System for cytologically indeterminate thyroid nodules.使用美国放射学院甲状腺影像报告和数据系统对细胞学不确定的甲状腺结节进行癌症风险评估。
Am J Surg. 2022 Aug;224(2):653-656. doi: 10.1016/j.amjsurg.2022.02.061. Epub 2022 Mar 2.
7
Comparison of Core Needle Biopsy and Repeat Fine-Needle Aspiration in Avoiding Diagnostic Surgery for Thyroid Nodules Initially Diagnosed as Atypia/Follicular Lesion of Undetermined Significance.对比甲状腺结节最初诊断为不典型/滤泡性病变不能明确意义时行核心针活检与重复细针抽吸以避免诊断性手术。
Korean J Radiol. 2022 Feb;23(2):280-288. doi: 10.3348/kjr.2021.0619. Epub 2022 Jan 4.
8
2021 Korean Thyroid Imaging Reporting and Data System and Imaging-Based Management of Thyroid Nodules: Korean Society of Thyroid Radiology Consensus Statement and Recommendations.2021 年韩国甲状腺影像报告和数据系统及基于影像学的甲状腺结节管理:韩国甲状腺放射学会共识声明和建议。
Korean J Radiol. 2021 Dec;22(12):2094-2123. doi: 10.3348/kjr.2021.0713. Epub 2021 Oct 26.
9
Ultrasonography and Fine-Needle Aspiration in Indeterminate Thyroid Nodules: A Systematic Review of Diagnostic Test Accuracy.超声检查和细针抽吸在甲状腺结节诊断中的应用:诊断试验准确性的系统评价。
Laryngoscope. 2022 Jan;132(1):242-251. doi: 10.1002/lary.29778. Epub 2021 Aug 19.
10
Combining the American Thyroid Association's Ultrasound Classification with Cytological Subcategorization Improves the Assessment of Malignancy Risk in Indeterminate Thyroid Nodules.将美国甲状腺协会的超声分类与细胞亚分类相结合,可提高对不确定甲状腺结节恶性风险的评估。
Thyroid. 2021 Jun;31(6):922-932. doi: 10.1089/thy.2019.0575. Epub 2020 Dec 10.